Expectorant

Arrowleaf balsamroot’s resinous root is decocted for coughs, colds and fevers.

The ethnobotanical record is the whole of it. No respiratory measurement of any kind exists.

Balsam fir needles are infused as a tea and used in steam inhalation for colds, coughs and chest congestion.

Nothing supports it beyond the general behaviour of aromatic monoterpenes. No mechanistic or clinical work exists for the species.

Balsam poplar bark is prepared as a decoction or tincture for coughs and colds, and the aromatic resin is what the tradition credits.

No respiratory study exists.

Black pepper is used for damp, cold coughs across the warming-pungent traditions, on the drying character of the spice rather than on any measured effect.

The one respiratory study on black pepper is an anti-inflammatory mouse lung-injury model, which measures inflammation rather than secretion. Piperine’s better-documented role is bioavailability enhancement.

Chickweed’s expectorant rationale is saponin irritation of the mucous membrane driving reflex bronchial secretion, the same route senega and ipecacuanha are credited with.

It is mechanistic rather than tested. No experimental respiratory study of chickweed exists, and the herb’s stronger traditional reputation is topical.

Douglas fir needles are infused and used in steam for colds and chest congestion, part of the same conifer-resin tradition as the firs and pines.

The ethnobotanical record is the whole of it.

Eyebright’s traditional use is remarkably consistent across Europe and remarkably narrow: inflamed, watering eyes, conjunctivitis and blepharitis, and internally the catarrhal states that accompany them, including hay fever, sinusitis and colds with a streaming nose. Its classic pairing is with goldenrod or elderflower.

That is an anticatarrhal action rather than an expectorant one, reducing the amount of secretion rather than mobilising it.

The only human data are an open-label uncontrolled cohort of 65 patients given single-dose eye drops for conjunctivitis. No respiratory endpoint has been measured.

Fennel’s expectorant listing rests on the traditional indications of upper respiratory catarrh and pharyngitis, and Culpeper recommended it for shortness of breath and wheezing.

It is a reasonable classification inference from an anethole-rich volatile oil in the same league as anise, with a deep and consistent tradition behind it. No study, citation or mechanism supports it directly.

Three separate traditions place garlic in the chest. Western herbal medicine uses it for respiratory infections, Chinese medicine treats it as warm, pungent and dispersing with a Lung-channel association, and Ayurveda gives it for respiratory congestion and excess Kapha.

Nothing in the research on garlic touches respiratory secretion, and its substantial cardiovascular evidence lends this nothing.

Goldenseal’s respiratory standing is as an anticatarrhal, the more accurate account of what berberine-bearing herbs do to an inflamed mucous membrane.

Its one airway measurement is a relaxant effect on isolated guinea-pig trachea, which is smooth muscle rather than secretion. No mucociliary or secretomotor study exists.

Tulsi is drunk as a tea for coughs and colds throughout Indian domestic practice, and the expectorant reading follows from a eugenol-rich volatile oil.

There is no respiratory research at all: no mucolytic, secretomotor, bronchodilator or antitussive data in humans or animals. The herb’s evidenced work is adaptogen and antimicrobial.

At roughly 25 mg, a fortieth of the emetic dose, ipecacuanha was said to increase bronchial secretion by vagal reflex from the stomach. A whole category of nauseating expectorants in older pharmacy rests on that idea.

The theory has no controlled human data behind it ^{13Reference 13The anatomy et al. · 1978ReviewThe anatomy, physiology, pharmacology and pathology of tracheobronchial mucus secretion and the use of expectorants (1978) — review. Pharmacol Ther B. https://pubmed.ncbi.nlm.nih.gov/32559/View study →}, and modern airway physiology does not obviously support it. It stands as the historical archetype rather than as a current recommendation.

Licorice’s pre-operative gargle trials are usually read as the controlled expression of its traditional demulcent and expectorant use. What they measured is soothing and less coughing.

No mucociliary, secretolytic or saponin-surfactant data appear anywhere for the herb. Culpeper’s dry-cough and hoarseness use is old and coherent, and expectoration is not what it describes.

Lobelia was dosed by the Eclectics just below the emetic threshold on the nauseant-expectorant rationale, that sub-emetic dosing moves mucus by the same reflex that produces vomiting.

Nothing measures it and nothing cites it. Expectorant and emetic are one dose-response continuum here rather than two separate actions, which is also the safety constraint.

Lomatium root is a traditional respiratory remedy of the North American interior, and the expectorant listing follows from that indication.

No research addresses mucus, cilia or airway secretion.

Magnolia bark’s classical Chinese indication includes phlegm-damp in the chest and airways, with cough, catarrh and wheezing, under the broader action of transforming damp.

There is no modern mucociliary or secretolytic data. Magnolia’s measured work is anxiolytic and sedative through honokiol and magnolol, and antispasmodic through TRPC4.

Marjoram is a gentle traditional cough-and-cold herb with the same aromatic chemistry as its relative oregano.

The traditional use is recorded and nothing has been measured. Marjoram’s better-attested work is carminative and nervine.

Marshmallow’s expectorant listing is old and widespread, part of the demulcent-as-relaxing-expectorant classification that ran through Western practice for centuries, and the root has been made into cough syrups for as long.

The modern data do not support expectoration. Rhamnogalacturonan had negligible impact on expectoration, reported as an advantage over codeine, and the herb’s best-characterised respiratory action is codeine-comparable cough suppression, examined on the antitussive page.

The traditional use is real and the mechanism behind it is soothing rather than expectorant.

Mullein’s expectorant reputation is credited to triterpene saponins, including verbascosaponin, thinning and mobilising bronchial secretions, with the demulcent half credited to leaf and flower mucilage coating irritated mucous membranes ^{14,15Reference 14Turker AU · 2005ReviewCommon mullein (Verbascum thapsus L.): recent advances in research — reviewView study →Reference 15Gupta A et al. · 2022ReviewHealth-promoting and disease-mitigating potential of Verbascum thapsus L. (common mullein): a reviewView study →}. Culpeper gave it for “cramps and convulsions” and for coughs alike.

The mechanism is plausible and the use is documented across European and North American traditions, but there is no clinical and no robust preclinical study of mullein for cough, catarrh or bronchial irritation.

It is a gentle herb rather than a forceful secretolytic, which is why it is chosen for dry, irritated coughs. Mucilage extracts into water, so a tea and a tincture are not interchangeable for this action.

Oregano is taken as a warm infusion, gargle or steam for congested chests and sore throats in European folk practice.

The nearest evidence is respiratory but anti-inflammatory rather than mucolytic: a carvacrol respiratory meta-analysis of mostly animal studies, and inclusion among herbal options in a rhinosinusitis network meta-analysis. No mucus-clearance, ciliary or secretomotor mechanism is established.

P. sidoides has genuine controlled trial data in acute bronchitis.

None of it establishes an expectorant mechanism, and there is no basis anywhere for mucociliary or secretomotor activity. The expectorant description was plausibly inferred from the indication rather than from the evidence, which points at antiviral and immune activity.

The traditional respiratory tonic is a warming needle infusion for coughs, sore throat and phlegm, and that preparation has no human data.

The only human respiratory evidence is a Pycnogenol asthma crossover trial ^{16Reference 16Hosseini S et al. · 2001RCTPycnogenol((R)) in the Management of Asthma — randomised placebo-controlledView study →} and its leukotriene-suppression rationale ^{17Reference 17Belcaro G et al. · 2011ReviewPycnogenol® improvements in asthma management — reviewView study →}, which used capsules of a P. pinaster bark extract as an anti-asthmatic add-on rather than a tonic tea.

The monoterpenes that would plausibly underwrite the tea, α-pinene, β-pinene and limonene ^{18Reference 18Politeo O et al. · 2011In vitroChemical composition and antimicrobial activity of the essential oil of endemic Dalmatian black pine (Pinus nigra ssp. dalmatica) — in vitroView study →}, have only been studied as antimicrobials. No mucolytic, mucociliary or bronchodilator mechanism has been established.

The controlled human data are for a multi-herb syrup pairing P. major with mallow, elecampane and helichrysum, which reduced cough in children. Plantain’s own contribution cannot be isolated from it.

The effect is attributed to mucilage, a soothing mechanism. No secretomotor or mucociliary mechanism has been proposed for the herb.

Silverweed has preclinical antitussive and expectorant activity recorded for it.

Nothing beyond that exists. No mechanism has been identified and there is no human data.

Almost everything slippery elm does rests on one physical property. The inner bark is roughly 7% mucilage, a hydrophilic polysaccharide that swells in water into a viscous gel and coats mucosal surfaces.

Applied to the throat and upper airway, that gel is what the traditional reputation rests on: it calms an irritated, tickly, unproductive cough by covering the surface that is triggering it.

The mechanism is a coating one rather than a mobilising one, so it belongs with the soothing half of cough practice rather than with the herbs that thin or shift mucus. No controlled trial has ever tested slippery elm on its own for any respiratory indication.

Spikenard root was made into a syrup for coughs and chest complaints through Eclectic and Appalachian practice, and that use is effectively the herb’s whole reputation.

No respiratory study of any kind exists for Aralia racemosa or any Aralia: no mucociliary, secretomotor, bronchodilator or antitussive work. All that supports the tradition is the balsamic volatile oil, whose composition has never been published.

The Shoshoni took an infusion of the needles for colds, and the Carrier of central British Columbia count subalpine fir among their frequently used medicinal plants, applying the softened pitch topically and using the plant for respiratory complaints.

The classification the uses imply is a warming aromatic resin, taken as a hot infusion for chest and head colds. The same logic is applied to spruce and pine pitch across the region.

Nothing has been measured. The record is ethnobotanical.

Tamarack’s inner bark is decocted, or the needles infused, and taken for coughs and sore throats, alongside the warm bark poultice used on wounds and burns.

The record is a modest folk one in eastern North America. The herb has no independent standing in Western materia medica and no pharmacopoeial monograph, and nothing respiratory has been measured.

Usnea’s respiratory listing rests on the traditional use for lung complaints plus the antibacterial reputation being applied to bronchitis.

The nearest research is an LPS acute-lung-injury mouse model, which is anti-inflammatory rather than expectorant and used an injected isolated compound. No respiratory-secretion research exists.

Yerba santa is the classic Californian respiratory herb, used in Indigenous and mission-era practice for coughs, colds, bronchial congestion and asthma, as a leaf infusion, chewed leaf, syrup or smoking blend. That tradition rather than pharmacology is what carries it.

The only modern support is constituent inference. The resinous leaf yields an essential oil dominated by 1,8-cineole, a monoterpene whose secretomotor and mucolytic action on airway epithelium is established in other plants and in eucalyptus-oil research, never in Eriodictyon itself ^{29Reference 29Satyal P et al. · 2026Chemical Composition of Eriodictyon californicum (California Yerba Santa) Cultivated in Ontario, Oregon, USA — analytical/phytochemistryView study →}.

No clinical or animal study of yerba santa as an expectorant exists ^{29Reference 29Satyal P et al. · 2026Chemical Composition of Eriodictyon californicum (California Yerba Santa) Cultivated in Ontario, Oregon, USA — analytical/phytochemistryView study →}.

The delivered dose of the marker is tiny and variable. Oil yield runs 0.80–3.40% of leaf with cineole at 0.6–35.5% of that oil ^{29Reference 29Satyal P et al. · 2026Chemical Composition of Eriodictyon californicum (California Yerba Santa) Cultivated in Ontario, Oregon, USA — analytical/phytochemistryView study →}, so a cup of infusion may carry essentially none, and a water infusion extracts a resinous volatile poorly in any case.